Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kezar Life Sciences, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 220K | Jul 24, 2023 | Direct | ||
Avidity Biosciences, Inc. | Director | Stock Option (Right to Buy) | 13.5K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNA | Avidity Biosciences, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
KZR | Kezar Life Sciences, Inc. | Jul 24, 2023 | 8 | $0 | 4 | Jul 26, 2023 | Chief Medical Officer |
RNA | Avidity Biosciences, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
KZR | Kezar Life Sciences, Inc. | Jan 8, 2023 | 1 | $0 | 4 | Jan 10, 2023 | Chief Medical Officer |
RNA | Avidity Biosciences, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
KZR | Kezar Life Sciences, Inc. | Jan 5, 2022 | 1 | $0 | 4 | Jan 7, 2022 | Chief Medical Officer |
RNA | Avidity Biosciences, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |